Esrum Biotech Holding ApS: Financial statements 2025
CVR: 44827662
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Esrum Biotech Holding ApS (CVR 44827662) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -9,172 and a net result of DKK -193,617 compared with DKK 1,236,174 the year before. Equity in the 2025 report amounted to DKK 3,429,532. The solvency ratio was 97.1%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -9,172
- Profit/Loss
- DKK -193,617
- Equity
- DKK 3,429,532
- Total Assets
- DKK 3,533,572
- Employees
- 1
Official annual report
How creditworthy is Esrum Biotech Holding ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Esrum Biotech Holding ApS has published its annual report for 2024. Gross profit came to DKK -20,425, and the net result was DKK 1,236,174.
About Esrum Biotech Holding ApS
Esrum Biotech Holding ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2024. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Mette Kirstine Agger. The company is owned by Mette Kirstine Agger, Nis Peter Agger and Søren Thye Agger. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -9,172 and a net result of DKK -193,617 compared with DKK 1,236,174 the year before. Equity in the 2025 report amounted to DKK 3,429,532.